Venture Catalysts records 9.60X return from Pee Safe exit
The early-stage investment platform has exited the personal hygiene brand following its recent $32 million funding led by health-focused private equity firm, OrbiMed.
Early-stage investment platform Venture Catalysts on Tuesday said it has taken a full exit from hygiene and wellness brand Pee Safe, recording a 9.6X return on invested capital.
The VC firm saw an extended internal rate of return (XIRR) of 30.53% for the fund and is limited partners. This means that the investment grew investors’ money at about 30.53% per year, on average.
Venture Catalysts first backed Pee Safe in August 2017. It also participated in the company’s pre-Series round, at a time when the company was expanding from a focused toilet hygiene product range to a broader personal hygiene and wellness portfolio.
“This exit is a validation of patient early-stage investing where we back founders before the market agrees. Pee Safe built category depth, distribution muscle, and brand trust. Delivering cash returns, not just markups, strengthens our promise to LPs and energizes our next cycle of investments for everyone involved today,” said Apoorva Ranjan Sharma, Founder, Venture Catalysts.
The exit came following Pee Safe’s recent $32 million funding round led by healthcare-focused private equity firm, OrbiMed. The company has scaled to an omnichannel model, with products available through more than 50,000 retail touch points across over 100 cities.
“Venture Catalysts believed in our mission early and were part of our first fund raise. As we welcome OrbiMed and scale faster, we are proud that early partners can realize meaningful outcomes. We see this as proof that strong brands can be built from India,” said Vikas Bagaria, Founder, Pee Safe.